⌘K

Login Start Free

Home/Filings/4/0001116679-08-001536

4//SEC Filing

AKESIS PHARMACEUTICALS, INC. 4

Accession 0001116679-08-001536

CIK 0001042420operating

View on SEC.gov Company Profile

Filed

Jun 19, 8:00 PM ET

Accepted

Jun 20, 5:19 PM ET

Size

8.4 KB

Accession

0001116679-08-001536

Insider Transaction Report

Form 4

Period: 2007-03-15

AKESIS PHARMACEUTICALS, INC.AKES

DirectorPresident and CEO

Transactions

Award
Options to Purchase Common Stock
2008-06-13+500,000→ 1,500,000 total
Exercise: $0.66Exp: 2018-06-13→ Common Stock (500,000 underlying)
Award
Options to Purchase Common Stock
2007-03-15+500,000→ 1,500,000 total
Exercise: $0.51Exp: 2017-03-15→ Common Stock (500,000 underlying)

Footnotes (3)

[F1]The options vest in monthly installments over a 31-month period commencing on the date of grant and subject to the continued status of reporting person as a service provider to the issuer on each vesting date.
[F2]The options vest in equal monthly installments over a three-year period commencing on the date of grant and subject to the continued status of reporting person as a service provider to the issuer on each vesting date.
[F3]Consists of 1,500,000 options to purchase Common Stock.

Documents

1 file

4
edgar.xmlPrimary
PRIMARY DOCUMENT

Issuer

AKESIS PHARMACEUTICALS, INC.

CIK 0001042420

Entity typeoperating

IncorporatedNV

Related Parties

1

filerCIK 0001042420

Filing Metadata

Form type: 4
Filed: Jun 19, 8:00 PM ET
Accepted: Jun 20, 5:19 PM ET
Size: 8.4 KB

View on SEC.gov